APE1 Promotes Pancreatic Cancer Proliferation through GFRα1/Src/ERK Axis-Cascade Signaling in Response to GDNF

Pancreatic cancer is the worst exocrine gastrointestinal cancer leading to the highest mortality. Recent studies reported that aberrant expression of apurinic/apyrimidinic endodeoxyribonuclease 1 (APE1) is involved in uncontrolled cell growth. However, the molecular mechanism of APE1 biological role...

Full description

Bibliographic Details
Main Authors: Yoo-Duk Choi, Ji-Yeon Jung, Minwoo Baek, Sheema Khan, Peter I. Song, Sunhyo Ryu, Joo-Yeon Koo, Subhash C. Chauhan, Andrew Tsin, Chan Choi, Won Jae Kim, Mihwa Kim
Format: Article
Language:English
Published: MDPI AG 2020-05-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/21/10/3586
_version_ 1797567564609486848
author Yoo-Duk Choi
Ji-Yeon Jung
Minwoo Baek
Sheema Khan
Peter I. Song
Sunhyo Ryu
Joo-Yeon Koo
Subhash C. Chauhan
Andrew Tsin
Chan Choi
Won Jae Kim
Mihwa Kim
author_facet Yoo-Duk Choi
Ji-Yeon Jung
Minwoo Baek
Sheema Khan
Peter I. Song
Sunhyo Ryu
Joo-Yeon Koo
Subhash C. Chauhan
Andrew Tsin
Chan Choi
Won Jae Kim
Mihwa Kim
author_sort Yoo-Duk Choi
collection DOAJ
description Pancreatic cancer is the worst exocrine gastrointestinal cancer leading to the highest mortality. Recent studies reported that aberrant expression of apurinic/apyrimidinic endodeoxyribonuclease 1 (APE1) is involved in uncontrolled cell growth. However, the molecular mechanism of APE1 biological role remains unrevealed in pancreatic cancer progression. Here, we demonstrate that APE1 accelerates pancreatic cancer cell proliferation through glial cell line-derived neurotrophic factor (GDNF)/glial factor receptor α1 (GFRα1)/Src/ERK axis-cascade signaling. The proliferation of endogenous APE1 expressed-MIA PaCa-2, a human pancreatic carcinoma cell line, was increased by treatment with GDNF, a ligand of GFRα1. Either of downregulated APE1 or GFRα1 expression using small interference RNA (siRNA) inhibited GDNF-induced cancer cell proliferation. The MEK-1 inhibitor PD98059 decreased GDNF-induced MIA PaCa-2 cell proliferation. Src inactivation by either its siRNA or Src inhibitor decreased ERK-phosphorylation in response to GDNF in MIA PaCa-2 cells. Overexpression of GFRα1 in APE1-deficient MIA PaCa-2 cells activated the phosphorylation of Src and ERK. The expression of both APE1 and GFRα1 was gradually increased as progressing pancreatic cancer grades. Our results highlight a critical role for APE1 in GDNF-induced pancreatic cancer cell proliferation through APE1/GFRα1/Src/ERK axis-cascade signaling and provide evidence for future potential therapeutic drug targets for the treatment of pancreatic cancer.
first_indexed 2024-03-10T19:43:46Z
format Article
id doaj.art-60efd41876964aea905d400aa63baada
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T19:43:46Z
publishDate 2020-05-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-60efd41876964aea905d400aa63baada2023-11-20T00:58:56ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672020-05-012110358610.3390/ijms21103586APE1 Promotes Pancreatic Cancer Proliferation through GFRα1/Src/ERK Axis-Cascade Signaling in Response to GDNFYoo-Duk Choi0Ji-Yeon Jung1Minwoo Baek2Sheema Khan3Peter I. Song4Sunhyo Ryu5Joo-Yeon Koo6Subhash C. Chauhan7Andrew Tsin8Chan Choi9Won Jae Kim10Mihwa Kim11Department of Pathology, Chonnam National University Medical School, Gwangju 61186, KoreaDental Science Research Institute, Medical Research Center for Biomineralization Disorders, School of Dentistry, Chonnam National University, Gwangju 61186, KoreaDepartment of Pharmacy Practice and Pharmaceutical Sciences, College of Pharmacy, University of Minnesota, Duluth, MN 55812, USADepartment of Immunology & Microbiology, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX 78504, USADepartment of Molecular Science, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX 78504, USADivision of Pulmonary and Critical Care Medicine, Department of Medicine, Boston University Medical Campus, Boston, MA 02118, USADepartment of Pathology, Chonnam National University Medical School, Gwangju 61186, KoreaDepartment of Immunology & Microbiology, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX 78504, USADepartment of Molecular Science, School of Medicine, University of Texas Rio Grande Valley, McAllen, TX 78504, USADepartment of Pathology, Chonnam National University Hwasun Hospital, Hwasun 58128, KoreaDental Science Research Institute, Medical Research Center for Biomineralization Disorders, School of Dentistry, Chonnam National University, Gwangju 61186, KoreaDepartment of Pathology, Chonnam National University Medical School, Gwangju 61186, KoreaPancreatic cancer is the worst exocrine gastrointestinal cancer leading to the highest mortality. Recent studies reported that aberrant expression of apurinic/apyrimidinic endodeoxyribonuclease 1 (APE1) is involved in uncontrolled cell growth. However, the molecular mechanism of APE1 biological role remains unrevealed in pancreatic cancer progression. Here, we demonstrate that APE1 accelerates pancreatic cancer cell proliferation through glial cell line-derived neurotrophic factor (GDNF)/glial factor receptor α1 (GFRα1)/Src/ERK axis-cascade signaling. The proliferation of endogenous APE1 expressed-MIA PaCa-2, a human pancreatic carcinoma cell line, was increased by treatment with GDNF, a ligand of GFRα1. Either of downregulated APE1 or GFRα1 expression using small interference RNA (siRNA) inhibited GDNF-induced cancer cell proliferation. The MEK-1 inhibitor PD98059 decreased GDNF-induced MIA PaCa-2 cell proliferation. Src inactivation by either its siRNA or Src inhibitor decreased ERK-phosphorylation in response to GDNF in MIA PaCa-2 cells. Overexpression of GFRα1 in APE1-deficient MIA PaCa-2 cells activated the phosphorylation of Src and ERK. The expression of both APE1 and GFRα1 was gradually increased as progressing pancreatic cancer grades. Our results highlight a critical role for APE1 in GDNF-induced pancreatic cancer cell proliferation through APE1/GFRα1/Src/ERK axis-cascade signaling and provide evidence for future potential therapeutic drug targets for the treatment of pancreatic cancer.https://www.mdpi.com/1422-0067/21/10/3586APE1GFRα1Src/ERKpancreatic cancerproliferation
spellingShingle Yoo-Duk Choi
Ji-Yeon Jung
Minwoo Baek
Sheema Khan
Peter I. Song
Sunhyo Ryu
Joo-Yeon Koo
Subhash C. Chauhan
Andrew Tsin
Chan Choi
Won Jae Kim
Mihwa Kim
APE1 Promotes Pancreatic Cancer Proliferation through GFRα1/Src/ERK Axis-Cascade Signaling in Response to GDNF
International Journal of Molecular Sciences
APE1
GFRα1
Src/ERK
pancreatic cancer
proliferation
title APE1 Promotes Pancreatic Cancer Proliferation through GFRα1/Src/ERK Axis-Cascade Signaling in Response to GDNF
title_full APE1 Promotes Pancreatic Cancer Proliferation through GFRα1/Src/ERK Axis-Cascade Signaling in Response to GDNF
title_fullStr APE1 Promotes Pancreatic Cancer Proliferation through GFRα1/Src/ERK Axis-Cascade Signaling in Response to GDNF
title_full_unstemmed APE1 Promotes Pancreatic Cancer Proliferation through GFRα1/Src/ERK Axis-Cascade Signaling in Response to GDNF
title_short APE1 Promotes Pancreatic Cancer Proliferation through GFRα1/Src/ERK Axis-Cascade Signaling in Response to GDNF
title_sort ape1 promotes pancreatic cancer proliferation through gfrα1 src erk axis cascade signaling in response to gdnf
topic APE1
GFRα1
Src/ERK
pancreatic cancer
proliferation
url https://www.mdpi.com/1422-0067/21/10/3586
work_keys_str_mv AT yoodukchoi ape1promotespancreaticcancerproliferationthroughgfra1srcerkaxiscascadesignalinginresponsetogdnf
AT jiyeonjung ape1promotespancreaticcancerproliferationthroughgfra1srcerkaxiscascadesignalinginresponsetogdnf
AT minwoobaek ape1promotespancreaticcancerproliferationthroughgfra1srcerkaxiscascadesignalinginresponsetogdnf
AT sheemakhan ape1promotespancreaticcancerproliferationthroughgfra1srcerkaxiscascadesignalinginresponsetogdnf
AT peterisong ape1promotespancreaticcancerproliferationthroughgfra1srcerkaxiscascadesignalinginresponsetogdnf
AT sunhyoryu ape1promotespancreaticcancerproliferationthroughgfra1srcerkaxiscascadesignalinginresponsetogdnf
AT jooyeonkoo ape1promotespancreaticcancerproliferationthroughgfra1srcerkaxiscascadesignalinginresponsetogdnf
AT subhashcchauhan ape1promotespancreaticcancerproliferationthroughgfra1srcerkaxiscascadesignalinginresponsetogdnf
AT andrewtsin ape1promotespancreaticcancerproliferationthroughgfra1srcerkaxiscascadesignalinginresponsetogdnf
AT chanchoi ape1promotespancreaticcancerproliferationthroughgfra1srcerkaxiscascadesignalinginresponsetogdnf
AT wonjaekim ape1promotespancreaticcancerproliferationthroughgfra1srcerkaxiscascadesignalinginresponsetogdnf
AT mihwakim ape1promotespancreaticcancerproliferationthroughgfra1srcerkaxiscascadesignalinginresponsetogdnf